Xeris Biopharma Holdings Inc is a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Paul R. Edick$250.7M
Market Cap • 23/04/20242005
(há 19 anos)
2018
(6 years ago)
NASDAQ
Listagem
Chicago
Sede • Illinois355
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
XERSSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.